You just read:

Research and Markets - Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis Report 2016-2022 - AstraZeneca, BMS, Roche, Innate Pharma, Incyte Corporation and MSD are Ahead of the Game

News provided by

Research and Markets

20 May, 2016, 13:10 ET